SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950135-07-004550
Filing Date
2007-08-01
Accepted
2007-07-31 21:37:49
Documents
9
Period of Report
2007-06-30

Document Format Files

Seq Description Document Type Size
1 IDERA PHARMACEUTICALS, INC. b65880ipe10vq.htm 10-Q 292508
2 EX-10.1 LETTER AGREEMENT DATED MAY 17, 2007, ROBERT G. ANDERSEN b65880ipexv10w1.txt EX-10.1 24944
3 EX-10.2 PROMISSORY NOTE DATED JUNE 12, 2007 b65880ipexv10w2.htm EX-10.2 20303
4 EX-10.3 MASTER SECURITY AGREEMENT DATED APRIL 23, 2007 b65880ipexv10w3.htm EX-10.3 49545
5 EX-10.4 FORM OF RESTRICTED STOCK AGREEMENT, 2005 STOCK INCENTIVE PLAN b65880ipexv10w4.htm EX-10.4 20327
6 EX-31.1 SECTION 302 CERTIFICATION OF CEO b65880ipexv31w1.htm EX-31.1 5841
7 EX-31.2 SECTION 302 CERTIFICATION OF CFO b65880ipexv31w2.htm EX-31.2 5856
8 EX-32.1 SECTION 906 CERTIFICATION OF CEO b65880ipexv32w1.htm EX-32.1 3036
9 EX-32.2 SECTION 906 CERTIFICATION OF CFO b65880ipexv32w2.htm EX-32.2 3050
  Complete submission text file 0000950135-07-004550.txt   426915
Mailing Address 345 VASSAR STREET CAMBRIDGE MA 02139
Business Address 345 VASSAR STREET CAMBRIDGE MA 02139 6176795500
IDERA PHARMACEUTICALS, INC. (Filer) CIK: 0000861838 (see all company filings)

IRS No.: 043072298 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-31918 | Film No.: 071014204
SIC: 2836 Biological Products, (No Diagnostic Substances)